Clinical Guidelines
CCA’s Clinical Guidelines represent the current standard of care for screening and/or management of specific diseases for which there are special considerations that apply to the complex health and social conditions of our members.
CCA strongly supports the use of evidence-based medicine and decision-making. We include the following information to provide quality resources to assist providers in taking care of their patients who have complex care needs. Guidelines can be used as a point of reference when making decisions regarding the care of a patient. We believe shared decision-making between the clinician and patient result in the best outcomes.
We hope that the following guidelines are helpful in decision-making. They have been developed by recognized experts and reviewed by CCA’s Clinical and Practice Guidelines Committee.
Guidelines and Assessment Tools
| GUIDELINES | SOURCE | APPROVED BY CCA |
| Cervical Cancer Screening Guidelines | 2019 USPSTF | April 2020 |
| Disability Competent Care (Webinar) | Resources for Integrated Care 2017 | April 2020 |
| Depression Screening for At Risk Individuals | 2016 USPSTF | April 2020 |
| Guideline for Prescribing Opioids for Chronic Pain | CDC 2019 | April 2020 |
Assessment Tools
| TOPIC | SOURCE | CCA APPROVED DATE |
| PROMIS-29 | PROMIS® | April 2020 |
| PHQ-9 | SAMHSA | April 2020 |
| PHQ-9 Spanish | SAMHSA | April 2020 |
| AUDIT | WHO | April 2020 |
| AUDIT Spanish | WHO | April 2020 |
| DAST | CDC | April 2020 |
| DAST Spanish | CDC | April 2020 |